Insider Trading activities at Icosavax, Inc. (ICVX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Icosavax, Inc. (ICVX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Icosavax, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1786255.

Total stock buying since 2021: $51,556,893.
Total stock sales since 2021: $6,775,546.
Total stock option exercises since 2021: $1,312,816.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Icosavax, Inc.* (*ICVX*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2024	0	$0	15,000	$229,380	113,016	$107,735
2023	0	$0	397,857	$5,549,198	360,941	$931,640
2022	226,443	$1,136,613	110,563	$996,968	277,486	$254,685
2021	3,361,352	$50,420,280	0	$0	22,598	$18,756

Table 2. Monthly summary of insider trading at *Icosavax, Inc.* (*ICVX*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2024-02	0	$0	15,000	$229,380	15,000	$15,600
2024-01	0	$0	0	$0	98,016	$92,135
2023-12	0	$0	195,965	$3,031,908	165,917	$240,579
2023-08	0	$0	0	$0	3,000	$2,520
2023-07	0	$0	36,421	$327,700	16,356	$17,010
2023-05	0	$0	10,000	$100,000	0	$0
2023-04	0	$0	20,443	$129,179	20,443	$21,260
2023-03	0	$0	5,000	$38,735	0	$0
2023-02	0	$0	23,655	$251,195	10,677	$11,104
2023-01	0	$0	106,373	$1,670,481	144,548	$639,167
2022-12	0	$0	66,764	$598,405	14,369	$12,069
2022-09	0	$0	1,813	$8,834	0	$0
2022-08	0	$0	26,735	$177,707	0	$0
2022-07	0	$0	5,251	$37,322	7,185	$6,035
2022-04	42,225	$299,797	0	$0	0	$0
2022-03	184,218	$836,816	10,000	$174,700	39,926	$33,537
2022-02	0	$0	0	$0	125,313	$117,793
2022-01	0	$0	0	$0	90,693	$85,251
2021-11	0	$0	0	$0	22,598	$18,756
2021-08	3,361,352	$50,420,280	0	$0	0	$0

Table 3. Detailed insider trading at *Icosavax, Inc.* (*ICVX*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2024-02-01	Simpson Adam K. (Chief Executive Officer)	Sale	15,000	15.29	229,380
2024-02-01	Simpson Adam K. (Chief Executive Officer)	Option Ex	15,000	1.04	15,600
2024-01-22	Simpson Adam K. (Chief Executive Officer)	Option Ex	98,016	.94	92,135
2023-12-21	Simpson Adam K. (Chief Executive Officer)	Sale	90,000	15.44	1,389,150
2023-12-21	Simpson Adam K. (Chief Executive Officer)	Option Ex	165,917	1.45	240,579
2023-12-20	Kanesa-thasan Niranjan (Chief Medical Officer)	Sale	11,884	15.46	183,690
2023-12-20	Cearley Cassia (Chief Business Officer)	Sale	7,934	15.46	122,635
2023-12-20	Simpson Adam K. (Chief Executive Officer)	Sale	62,205	15.46	961,502
2023-12-20	Russo Thomas Joseph (Chief Financial Officer)	Sale	15,183	15.46	234,744
2023-12-13	Cearley Cassia (Chief Business Officer)	Sale	8,759	16.00	140,187
2023-08-01	Simpson Adam K. (Chief Executive Officer)	Option Ex	3,000	.84	2,520
2023-07-31	Kanesa-thasan Niranjan (Chief Medical Officer)	Sale	3,323	8.86	29,448
2023-07-31	Cearley Cassia (Chief Business Officer)	Sale	1,888	8.86	16,731
2023-07-31	Simpson Adam K. (Chief Executive Officer)	Sale	11,788	8.86	104,465
2023-07-31	Russo Thomas Joseph (Chief Financial Officer)	Sale	3,066	8.86	27,170
2023-07-03	Holtzman Douglas (Chief Scientific Officer)	Sale	16,356	9.16	149,886
2023-07-03	Holtzman Douglas (Chief Scientific Officer)	Option Ex	16,356	1.04	17,010
2023-05-23	Cearley Cassia (Chief Business Officer)	Sale	10,000	10.00	100,000
2023-04-03	Holtzman Douglas (Chief Scientific Officer)	Sale	20,443	6.32	129,179
2023-04-03	Holtzman Douglas (Chief Scientific Officer)	Option Ex	20,443	1.04	21,260
2023-03-06	Cearley Cassia (Chief Business Officer)	Sale	5,000	7.75	38,735
2023-02-15	Simpson Adam K. (Chief Executive Officer)	Option Ex	10,677	1.04	11,104
2023-02-14	Holtzman Douglas (Chief Scientific Officer)	Sale	3,349	10.17	34,066
2023-02-13	Bekiroglu Elizabeth (General Counsel & Corp. Sec.)	Sale	5,922	10.69	63,323
2023-02-13	Holtzman Douglas (Chief Scientific Officer)	Sale	1,522	10.69	16,274
2023-02-13	Kanesa-thasan Niranjan (Chief Medical Officer)	Sale	1,794	10.69	19,183
2023-02-13	Cearley Cassia (Chief Business Officer)	Sale	1,660	10.69	17,750
2023-02-13	Simpson Adam K. (Chief Executive Officer)	Sale	7,506	10.69	80,261
2023-02-13	Russo Thomas Joseph (Chief Financial Officer)	Sale	1,902	10.69	20,338
2023-01-30	Cearley Cassia (Chief Business Officer)	Option Ex	25,102	.84	21,085
2023-01-25	Simpson Adam K. (Chief Executive Officer)	Option Ex	13,073	.94	12,288
2023-01-04	Kanesa-thasan Niranjan (Chief Medical Officer)	Sale	106,373	15.70	1,670,481
2023-01-04	Kanesa-thasan Niranjan (Chief Medical Officer)	Option Ex	106,373	5.70	605,794
2022-12-23	Simpson Adam K. (Chief Executive Officer)	Option Ex	14,369	.84	12,069
2022-12-21	Simpson Adam K. (Chief Executive Officer)	Sale	66,764	8.96	598,405
2022-09-08	Bekiroglu Elizabeth (General Counsel & Corp. Sec.)	Sale	1,813	4.87	8,834
2022-08-02	Richardson Charles E (SVP, Technical Operations)	Sale	371	6.70	2,487
2022-08-02	Holtzman Douglas (Chief Scientific Officer)	Sale	453	6.70	3,036
2022-08-02	Kanesa-thasan Niranjan (Chief Medical Officer)	Sale	543	6.70	3,640
2022-08-02	Cearley Cassia (Chief Business Officer)	Sale	303	6.70	2,031
2022-08-02	Simpson Adam K. (Chief Executive Officer)	Sale	1,904	6.70	12,764
2022-08-02	Russo Thomas Joseph (Chief Financial Officer)	Sale	495	6.70	3,318
2022-08-01	Richardson Charles E (SVP, Technical Operations)	Sale	1,368	6.64	9,079
2022-08-01	Holtzman Douglas (Chief Scientific Officer)	Sale	9,337	6.64	61,969
2022-08-01	Kanesa-thasan Niranjan (Chief Medical Officer)	Sale	2,001	6.64	13,280
2022-08-01	Cearley Cassia (Chief Business Officer)	Sale	1,118	6.64	7,420
2022-08-01	Simpson Adam K. (Chief Executive Officer)	Sale	7,017	6.64	46,571
2022-08-01	Russo Thomas Joseph (Chief Financial Officer)	Sale	1,825	6.64	12,112
2022-07-29	Richardson Charles E (SVP, Technical Operations)	Sale	479	7.11	3,404
2022-07-29	Holtzman Douglas (Chief Scientific Officer)	Sale	585	7.11	4,158
2022-07-29	Kanesa-thasan Niranjan (Chief Medical Officer)	Sale	701	7.11	4,982
2022-07-29	Cearley Cassia (Chief Business Officer)	Sale	391	7.11	2,779
2022-07-29	Simpson Adam K. (Chief Executive Officer)	Sale	2,456	7.11	17,457
2022-07-29	Russo Thomas Joseph (Chief Financial Officer)	Sale	639	7.11	4,542
2022-07-01	Simpson Adam K. (Chief Executive Officer)	Option Ex	7,185	.84	6,035
2022-04-01	Mcdade Mark (Director)	Buy	42,225	7.10	299,797
2022-03-29	Shah Rajeev M.	Buy	8,900	4.75	42,275
2022-03-28	Simpson Adam K. (Chief Executive Officer)	Option Ex	4,789	.84	4,022
2022-03-28	Shah Rajeev M.	Buy	175,318	4.53	794,541
2022-03-18	Cearley Cassia (Chief Business Officer)	Option Ex	35,137	.84	29,515
2022-03-07	Cearley Cassia (Chief Business Officer)	Sale	10,000	17.47	174,700
2022-02-14	Richardson Charles E (SVP, Technical Operations)	Option Ex	72,561	.94	68,207
2022-02-02	Kanesa-thasan Niranjan (Chief Medical Officer)	Option Ex	52,752	.94	49,586
2022-01-26	Simpson Adam K. (Chief Executive Officer)	Option Ex	90,693	.94	85,251
2021-11-15	Cearley Cassia (Chief Business Officer)	Option Ex	22,598	.83	18,756
2021-08-02	Kanesa-thasan Niranjan (Chief Medical Officer)	Buy	6,666	15.00	99,990
2021-08-02	Nicholson Jonathan (Other)	Buy	133,334	15.00	2,000,010
2021-08-02	Shah Rajeev M.	Buy	2,666,666	15.00	39,999,990
2021-08-02	Gould Terry P (Director)	Buy	133,334	15.00	2,000,010
2021-08-02	Mcdade Mark (Other)	Buy	221,351	15.00	3,320,265
2021-08-02	Adams Street Partners Llc	Buy	133,334	15.00	2,000,010
2021-08-02	Sanofi (10% Owner)	Buy	66,667	15.00	1,000,005

Insider trading activities including stock purchases, stock sales, and option exercises of ICVX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Icosavax, Inc. (symbol ICVX, CIK number 1786255) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month